Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Maxim Group Initiates Coverage On Helius Medical Tech with Buy Rating, Announces Price Target of $1

Maxim Group Initiates Coverage On Helius Medical Tech with Buy Rating, Announces Price Target of $1

Maxim Group analyst Anthony Vendetti initiates coverage on Helius Medical Tech (NASDAQ:HSDT) with a Buy rating and announces Price Target of $1.

byBenzinga Newsdesk

December 20, 2022

1 minute read

Maxim Group analyst Anthony Vendetti initiates coverage on Helius Medical Tech (NASDAQ:HSDT) with a Buy rating and announces Price Target of $1.

RBC Capital Upgrades Masco to Outperform, Raises Price Target to $57

By Benzinga Newsdesk

February 10, 5:59 AM

RBC Capital analyst Mike Dahl upgrades Masco (NYSE:MAS) from Sector Perform to Outperform and raises the price target from $49 to $57.

MAS

Ellington Financial Announces Estimated Book Value Per Common Share Of $15.05 As Of December 31, 2022

By Benzinga Newsdesk

January 26, 5:41 PM

Ellington Financial Inc. (NYSE:EFC) (the "Company") today announced its estimated book value per share of common stock of $15.05 as of December 31, 2022. This estimate includes the effect of the

EFC

Apple’s Debt Overview

By Benzinga Insights

February 28, 11:52 AM

Shares of Apple Inc. (NASDAQ:AAPL) moved lower by 0.32% in the past three months. Before having a look at the importance of debt, let's look at how much debt Apple has.

AAPL